Volume 26, Number 7—July 2020
Dispatch
Carbapenem Resistance Conferred by OXA-48 in K2-ST86 Hypervirulent Klebsiella pneumoniae, France
Table
Characteristic | Kpn154 strain | Kpn2166 strain |
---|---|---|
Patient age, y/sex | 35/M | 70/M |
Sample, context |
Urine, community-acquired UTI |
Feces, hospital-acquired intestinal carriage |
MIC, μg/mL | ||
Ertapenem | 2 | 32 |
Imipenem |
10 |
10 |
Meropenem | 2 | 4 |
Ceftazidime |
0.125 |
>256 |
Ceftriaxone | 0.5 | >256 |
Cefotaxime |
0.5 |
>256 |
Cefepime | 0.25 | >256 |
Aztreonam |
0.06 |
>256 |
Temocillin | 256 | 32 |
Tigecyclin |
1 |
4 |
Colistin |
0.5 |
0.5 |
Genome size, sequencing depth | 5,555,907 bp, 120× | 5,649,836 bp, 145× |
Genotype | K2-ST86 | K2-ST86 |
Resistance replicon, bp |
IncL, 100,326 |
IncN, 61,761 |
Resistance marker | blaOXA-48 | blaCTX-M-15, ΔompK36, ΔramR |
Virulence replicon |
IncHI1B/IncFIB, 215,306 |
IncHI1B/IncFIB, 226,677 |
Capsule regulator | rmpA.2, rmpA2† | rmpA.2, ΔrmpA2‡ |
Aerobactin-ST§ |
AbST1: iucA1B1C1D1iutA1 |
AbST1: iucA1B1C1D1iutA1 |
Salmochelin-ST§ | SmST1: iroB1C1D1N1 | SmST1: iroB1C1D1N1 |
Yersiniabactin-ST§ | ICEKp3-YbST202LV | ICEKp12like- YbST13LV |
*K, capsular genotype; ST, sequence type; UTI, urinary tract infection.
†New rmpA2 allele.
‡Truncated allele harboring a frameshift mutation at base 222.
§Genotyped based on Kleborate schemes.
Page created: April 10, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.